Breakthroughs in the War on Cancer

BioSupply Trends Quarterly Fall 2016 Healthcare Innovation

As the number of cancer cases continues to rise, scientists are bringing to light exciting discoveries that are being used to create targeted therapies to treat and, it is hoped, to eventually cure cancer.

Narrative Medicine: How Stories of Illness Affect Caregiving

Narrative Medicine: How Stories of Illness Affect Caregiving

A physician diagnoses the condition and either treats it or refers the patient to someone else for treatment. End of story. Or is that just the beginning of the story? Narrative medicine challenges the medical model by bringing a new tool to the table: the story of the patient.

Treating PANDAS

Current treatments for PANDAS have been shown to be relatively effective, but could surgical treatments such as tonsillectomy and adenoidectomy offer more effective results?

The Escalating Diabetes Epidemic

Will the evolving therapeutic guidelines for treating diabetes, as well as managing its risks and complications, stem the tide of this costly and sometimes deadly disease?

Severe PIs: Cutting-Edge Science Turns Tragedies to Cures

For decades, donor blood stem cell transplantation has been the only potential cure for severe primary immunodeficiency disorders, but it has been limited by failure and serious complication risks. Now, a trifecta of scientific advances is transforming the prognosis for children once defenseless against life-threatening infections.

Saving the Aging Brain: Grifols Attacks Alzheimer’s Disease Head-On

Grifols, the world’s third largest manufacturer of plasma-based therapeutics and a leader in immunohematology and transfusion medicine diagnostics, has been patiently developing a novel approach to treatment of AD, based on plasma exchange and replacement with donor human albumin.

Alzheimer’s: Can It Be Stopped?

There is no effective treatment for this devastating disease, but research is paving the way for better diagnostic methods and new therapies to prevent, slow or stop it.